STEM CELL- mit STEM CELL gute Kursgewine erzielen


Seite 1 von 50
Neuester Beitrag: 20.08.21 09:59
Eröffnet am:21.01.10 14:04von: brunnetaAnzahl Beiträge:2.235
Neuester Beitrag:20.08.21 09:59von: BigbqqLeser gesamt:135.487
Forum:Hot-Stocks Leser heute:20
Bewertet mit:
12


 
Seite: < 1 | 2 | 3 | 4 |
48 | 49 | 50 50  >  

27083 Postings, 6037 Tage brunnetaSTEM CELL- mit STEM CELL gute Kursgewine erzielen

 
  
    #1
12
21.01.10 14:04
STEM CELL INNOVATIONS – WKN A0JDMC - mit Stammzellenforschung gute Kursgewinne erzielen

STEM CELL INNOVATIONS – WKN A0JDMC - mit Stammzellenforschung gute Kursgewinne erzielen

Die Die Analysten vom tradersreport würden eine erste sehr spekulative Longposition in den Aktien der  STEM CELL INNOVATIONS mit der WKN A0JDMC bis zu Kursen von 0,003 € eingehen.

Das Thema Stammzellenforschung wurde zum Jahresbeginn 2009 bereits schon einmal angestoßen. Durch die Finanzkrise ist dieses sehr interessante und lukrative Thema etwas aus der Tagespresse verschwunden. Ganz zu Unrecht, da dieses Thema auf der Agenda des neuen US-Präsidenten steht. Neben dem angeschlagenen US-Gesundheitssystems, der Finanzkrise und dem Solarsektor bzw. erneuerbare Energien, steht dieses Thema mit oben auf der Aufgabenliste von Herrn Obama. Nun ist das Spezialgebiet sehr groß und nicht alle Teilbereiche in der Stammzellenforschung werden auch profitabel nutzbar sein. Umso wichtiger wird es sein den richtigen Analyseansatz anzuwenden, um die möglichen Blockbuster-Unternehmen von den lahmen Enten zu trennen.  

http://www.be24.at/blog/entry/629436
1210 Postings ausgeblendet.
Seite: < 1 | 2 | 3 | 4 |
48 | 49 | 50 50  >  

12 Postings, 7729 Tage MeheSECURITIES EXCHANGE ACT OF 1934 Release No. 66240

 
  
    #1212
1
07.02.12 23:39
Kann mir jemand sagen, was dies bedeutet?

http://www.sec.gov/litigation/admin/2012/34-66240.pdf  

196 Postings, 4559 Tage bonnie777@Mehe

 
  
    #1213
08.02.12 11:24
Das möchte ich auch wissen! Was bedeutet das?  

2957 Postings, 4607 Tage XXXTRADERLetzter Absatz

 
  
    #1214
1
08.02.12 16:15
Angesichts des Vorangehenden (STEMS CELLS) hält die Kommission es für notwendig und passend für den Schutz der Investoren, die Sanktionen aufzuerlegen.

XXXTRADER  

33 Postings, 5055 Tage X-Ray Specialistalso Tod?!

 
  
    #1215
09.02.12 09:26

2957 Postings, 4607 Tage XXXTRADERInfo

 
  
    #1216
09.02.12 09:30
es wäre besser, die Aktionäre zu entschädigen, als dass die Firma von der entsprechenden Kommission Sanktionen auferlegt bekommt!  

29 Postings, 8195 Tage boertienja wie jetzt ?

 
  
    #1217
09.02.12 10:56
kann ev. jemand hier etwas genauer erklären was jetzt Sache ist ?
welche Sanktionen sollten das dann sein und was heißt das für uns ?
danke  

12 Postings, 7729 Tage MeheGlobal Data Report

 
  
    #1218
18.03.12 18:48
Zumindest Global Data will an der Firma noch verdienen. Was es da wöhl noch zu analysieren gibt? das die Firma delistet ist wissen wir auch so. 250€, wer gibt die wohl aus?

Stem Cell Innovations, Inc. (SCLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published by GlobalData on Mar 05, 2012 , 23 pages


                    §Description Table of Contents
Stem Cell Innovations, Inc. (SCI) is a privately held biotechnology company, based in the US. The company is engaged in the discovery and development of human cell based drugs. Its core technologies concentrate on developing, growing, and manipulating human cells in the laboratory using proprietary technology. The company is into the development of a broad array of human primary cell models, which can be used as powerful research tools to form the basis of therapeutic breakthroughs. SCI has established many human pluripotent stem cell lines fetal gonadal tissue using defined conditions, and the PluriCell lines are established directly onto tissue culture plastic without using feeder layers or conditioned medium. The company also has in vitro hepatocyte screening, kits, compositions, and services for compound toxicity testing, ACTIVTox and PREDICTIVTox in store. SCI is headquartered at Houston in Texas, the US.

Stem Cell Innovations, Inc. (SCLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals and Healthcare eTrack deals database, and primary and secondary research.

Scope

   Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
   Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
   Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
   Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
   Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
   Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
   Business Description - A brief description of the company's operations.
   Key Employees - A list of the key executives of the company.
   Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
   Key Competitors - A list of the key competitors of the company.
   Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

   The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

   The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

   Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

   The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

   Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

   Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.  

60 Postings, 4490 Tage Bede112Sie zieht an mal wieder

 
  
    #1219
16.05.12 16:05

60 Postings, 4490 Tage Bede112++++++%$

 
  
    #1220
16.05.12 16:08

2957 Postings, 4607 Tage XXXTRADERUS62544S2005

 
  
    #1221
16.05.12 16:10
so etwa?  

60 Postings, 4490 Tage Bede112Sorry war falsch

 
  
    #1222
16.05.12 16:10

60 Postings, 4490 Tage Bede112Ja Multicell

 
  
    #1223
16.05.12 16:11

2957 Postings, 4607 Tage XXXTRADERwäre auch zu schön gewesen

 
  
    #1224
16.05.12 16:14
aber vielleicht im Soge von MultiCell?  

29 Postings, 8195 Tage boertienhat jemand zufällig Infos ?

 
  
    #1225
01.10.12 13:48
weiß jemand wie bzw. ob es weitergeht oder ob eh schon alles im Eimer ist ?  

15800 Postings, 4398 Tage nordküstenbauaus den Gräbern

 
  
    #1226
01.11.12 15:32
auferstanden STEM CELL

0,001 €  71.014.456 0,00%  08:24:03  

15800 Postings, 4398 Tage nordküstenbauStem Cell

 
  
    #1227
02.11.12 14:03
Order wurde auf grund einer kursaussetzung gelöscht, weiss jemand mehr zu diesem thema?  

4951 Postings, 6119 Tage 0815axAussetzung und Einstellung

 
  
    #1228
02.11.12 16:28

10 Postings, 5215 Tage BlackUserLöschung/-Streichung vom 03.11.12

 
  
    #1229
08.11.12 14:30

12 Postings, 7729 Tage MeheFirma exisitiert noch

 
  
    #1230
1
27.11.12 16:51
In dem unten aufgeführten Artikel wird eine stem cells Veranstaltung im nächsten Frühjahr angekündigt. Bei den teilnehmenden Firmen ist auch stem cell innovations aufgeführt.

Allerdings finde ich nach wie vor keine homepage.

http://www.finanznachrichten.de/...m-cell-therapy-use-in-2012-008.htm

26.11.2012 | 20:32

PR Newswire · Mehr Nachrichten von PR Newswire
Dramatic Rise in Stem Cell Therapy Use in 2012

PHILADELPHIA, Nov. 26, 2012 /PRNewswire/ --RRY Publications LLC today announced that the use of stem cell therapies in 2012 significantly exceeded forecasts which were originally presented at the February 2012 New York Stem Cell Summit. Said Robin Young, stem cell industry analyst and host of the New York meeting: "The range and scope of stem cell therapeutic use in the United States grew much faster than we'd forecasted earlier this year. Virtually all of the increases we're seeing are for adult stem cell therapies and, in particular, the use by physicians of both allograft and autologous stem cell products. It would not be an exaggeration to call this unexpected and remarkable growth."

Mr. Young's revised forecast of stem cell commercialization revenues for 2013-2020 will be presented at the February meeting in New York.

The companies, scientists and physicians that are at the forefront of this remarkable increase in stem cell therapeutic use will be presenting at the 8th Annual New York Stem Cell Summit. Listed below is the preliminary lineup of presenters for the 8th Annual Stem Cell Summit.

The Stem Cell Summit, an intensive one-day event, allows attendees to learn about the latest developments in the stem cell marketplace, evaluate the groundbreaking stem cell products physicians are using today, and discover the growing market potential in terms of revenues. For 2013, the Summit will feature 30+ presenters, a research review and debate session, and a special track on expanding the range of stem cell therapies.

The 8th Annual Stem Cell Summit will take place on Feb. 19, 2013, at Bridgewaters in the heart of New York City's historic South Street Seaport. The preliminary roster of companies featured will include representatives from 2012 presenters and new 2013 presenters.

Aastrom Biosciences, Inc.

Advanced Cell Technology

Aldagen, Inc.

AllCells, LLC.

Aruna Biomedical, Inc.

Athersys, Inc.

Bioheart Inc.

BioLife Solutions

BioTime Inc./Embryome Sciences, Inc.

Brainstorm Cell Therapeutics

Case Western Reserve University

CellCyte Genetics Corp.

Celgene Corporation

Celtigen Therapeutics

Cord Blood America, Inc. (CBAI.OB)

Core Dynamics Ltd.

Cytori Therapeutics, Inc.

Gamida Cell Ltd.

Garnet BioTherapeutics, Inc.

Histogen Inc

INCELL Corporation LLC

International Stem Cell Corporation

Lifenet Health

Lonza Group Ltd.
          
           
           
§
Medistem Inc.

Mesoblast Limited

MultiCell Technologies [MCET]

Neostem, Inc.

Neuralstem

Opexa Therapeutics, Inc.

Osiris Therapeutics, Inc.

Parcell Labs

Pathfinder Cell Therapy

Pervasis Therapeutics, Inc.

Pluristem Therapeutics, Inc.

Prochon Biotech, Ltd.

Progenitor Cell Therapy, LLC

Stem Cell Innovations

Stem Cell Therapeutics (SCTPF)

StemCells Inc.

TiGenix NV

Tissue Genesis, Inc.

TxCell

Vet-Stem, Inc.

ViaCyte

WuXi AppTec

In addition to the company and product overviews, Robin Young, president of RRY Publications and the organizer of the annual Stem Cell Summit, will deliver his updated 10-year market forecast for the industry.

8th Annual New York Stem Cell Summit Facts at a Glance

          

What:
           
§
Largest Gathering of Stem Cell Company Executives, Scientists, Investors, and Physicians

When:
                
§
February 19, 2013

Where:
          

Bridgewaters

           
§
11 Fulton Street

                
§
New York City

Who:
                
§
The Stem Cell Summit is organized by RRY Publications LLC

Admission:
                
§
$950 through November 2012

                
§
$1,500 Registration (February 1, 2013 - February 19, 2013 and onsite)

Information:
                
§
For more information on presentation or sponsorship opportunities, call Bharathi Kavalipati at

                
§
610-260-6462 or send an email to bharathi@ryortho.com


                
§
Additional information, including attendee registration details, is available at www.stemcellsummit.com

Contacts:
                
§
Suzanne Kirchner

                
§
RRY Publications LLC

          

501-251-1797

           
§
skirchner@ryortho.com  

4887 Postings, 5449 Tage ridgebackIst die Aktie mittlerweile bei Manitu? :o)))

 
  
    #1231
27.02.14 16:10
Wer weiß was Näheres? Finden tue ich zu der Firma nix mehr.

29 Postings, 8195 Tage boertienja das ist wirklich ein gute Frage !

 
  
    #1232
1
31.03.14 09:51
Wäre schön, wenn da jemand etwas wissen würde, dann ich habe noch eine Menge in meinem Depot liegen und weiß eigentlich nicht wie das weitergeht ?
Gehandelt wird schon lange nichts mehr, aber ganz weg sind sie scheinbar auch nicht, denn sonst würde diese Position ja aus meinem Depot gelöscht werden.

Ich habe keine Ahnung was hier abgeht !

 

9 Postings, 1175 Tage UrsulasjnhaLöschung

 
  
    #1234
25.04.21 00:11

Moderation
Zeitpunkt: 26.04.21 11:17
Aktionen: Löschung des Beitrages, Nutzer-Sperre für immer, Beitrag wird nicht mehr angezeigt.
Kommentar: Spam

 

 

10 Postings, 5215 Tage BlackUserHandelt es sich um folgende Firma?

 
  
    #1235
13.07.21 09:27
https://scia.io/

Aus welchem Grund findet seit längerem kein Handel mehr statt, obwohl die Aktie noch aktiv ist?  

756 Postings, 1989 Tage Bigbqqlange nichts passiert

 
  
    #1236
20.08.21 09:59
es gab mal Dividenden...  aber dieses Jahr noch nichts...  

Seite: < 1 | 2 | 3 | 4 |
48 | 49 | 50 50  >  
   Antwort einfügen - nach oben